COSTA, Lara Tania
 Distribuzione geografica
Continente #
NA - Nord America 787
EU - Europa 750
AS - Asia 140
OC - Oceania 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.684
Nazione #
US - Stati Uniti d'America 785
IE - Irlanda 258
IT - Italia 154
SE - Svezia 148
CN - Cina 102
PL - Polonia 57
FI - Finlandia 38
UA - Ucraina 30
SG - Singapore 24
DE - Germania 23
GB - Regno Unito 15
BE - Belgio 13
VN - Vietnam 8
IN - India 6
RU - Federazione Russa 5
CL - Cile 3
FR - Francia 3
AU - Australia 2
CA - Canada 2
CZ - Repubblica Ceca 2
A2 - ???statistics.table.value.countryCode.A2??? 1
ES - Italia 1
LV - Lettonia 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 1.684
Città #
Dublin 258
Chandler 138
Nyköping 117
Jacksonville 89
Warsaw 57
Catania 48
Princeton 48
Ann Arbor 47
Beijing 47
Dearborn 45
Cambridge 35
Messina 32
Des Moines 29
Medford 26
Ashburn 22
Boardman 19
Singapore 15
Wilmington 14
Brussels 13
San Mateo 13
Woodbridge 11
Villamagna 10
Dong Ket 8
Jinan 6
Nanjing 6
Rome 6
Shenyang 6
Viagrande 5
Caltagirone 4
Hebei 4
Hyderabad 4
La Jolla 4
Ningbo 4
Seattle 4
Tianjin 4
Haikou 3
Hangzhou 3
Helsinki 3
Houston 3
Los Angeles 3
Milan 3
Munich 3
New York 3
Norwalk 3
Palermo 3
Santiago 3
Turin 3
Vicenza 3
Washington 3
Acireale 2
Brno 2
Guangzhou 2
Jiaxing 2
Kemerovo 2
La Spezia 2
Lancaster 2
Leonforte 2
Marigliano 2
Pune 2
Reggio Emilia 2
Riverside 2
Saint Louis 2
Trecastagni 2
Boston 1
Bremen 1
Brooklyn 1
Christchurch 1
Clearwater 1
Edinburgh 1
Fuzhou 1
Kunming 1
Ladysmith 1
Lanzhou 1
Lappeenranta 1
Lishui 1
Madrid 1
Melbourne 1
Meppel 1
Novokuznetsk 1
Nuremberg 1
Oslo 1
Piazza Armerina 1
Saint Petersburg 1
Saint-Jean-sur-Richelieu 1
Shanghai 1
Taiyuan 1
Zhengzhou 1
Totale 1.292
Nome #
Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome 99
AMPA receptor antagonists: Synthesis and pharmacological evaluation 90
Activation of serotonin 5-HT7 receptors rescues hippocampal synaptic plasticity in a mouse model of Fragile X Syndrome through a cyclic AMP-mediated mechanism 82
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 68
Activation of serotonin 5-HT7 receptors modulates hippocampal synaptic plasticity by activation of adenylate cyclase and rescues learning and behavior in a mouse model of Fragile X Syndrome 68
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 62
Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice 59
Pituitary adenylate cyclase activating polypeptide (PACAP) modulates hippocampal synaptic transmission and plasticity: new therapeutic suggestions for Fragile X Syndrome. 57
Dysfunctions of metabotropic glutamate receptor subtype 5 (mGlu5) receptors in a mouse model of Fragile X syndrome 56
Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome. 54
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 53
ACTIVATION OF SEROTONIN TYPE 7 (5-HT7) RECEPTORS AS A NOVEL THERAPEUTIC STRATEGY IN FRAGILE X SYNDROME UNA NUOVA STRATEGIA TERAPEUTICA PER LA SINDROME DEL CROMOSOMA X FRAGILE BASATA SU NUOVE MOLECOLE ATTIVANTI I RECETTORI 5-HT7 PER LA SEROTONINA 53
New Indole derivatives as NMDA/NR2B rrceptor antagonists: design, synthesis and pharmacological properties 46
Altered mGlu5 receptor surface dynamics are linked to abnormal NMDA receptor function and plasticity in Fragile X Syndrome 46
Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome 46
Synthesis and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-Containing N-Methyl-d-aspartate Receptors 44
Serotonin 5-HT7 receptor activation rescues CA1 pyramidal neurons from mGluR-LTD in wild type and Fmr1 knockout mice. 44
5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission. 41
Activation of 5-HT7 receptors for serotonin rescues hippocampal synaptic plasticity in a mouse model of Fragile X Syndrome through a cyclic AMP-mediated mechanism involving Cyclin-dependent Kinase 5 and protein synthesis. 41
Studi computazionali per il design e la sintesi di nuovi antagonisti non-competitivi del recettore NMDA/NR2B 40
Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists 39
Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus. 38
Effects of serotonin on AMPA receptor-mediated synaptic transmission in rat and mouse hippocampus: different roles of 5-HT1A and 5-HT7 receptors during development. 38
Rational Design, Synthesis and Biological Profile of New Potent and Selective NMDA-NR2B Receptor Antagonists 37
Endogenous pituitary adenylate cyclase-activating polypeptide (PACAP) regulates synaptic transmission in rat hippocampus: opposite effects mediated by PAC1 and VPAC2 receptors and additional modulation of glutamate re-uptake. 37
Reversal of mGluR-LTD by 5-HT7 receptor activation in the hippocampus of wild type and Fmr1 knockout mice 36
Group I metabotropic glutamate receptors control proliferation, survival and differentiation of cultured neural progenitor cells isolated from the subventricular zone of adult mice. 35
Intracellular mechanisms responsible for serotonin-mediated reversal of metabotropic glutamate receptor-mediated long-term depression (mGluR-LTD) in wild-type and Fmr1 KO mouse hippocampus 35
Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists 33
Age-dependent modulation by serotonin of AMPA receptor-mediated synaptic transmission in rat and mouse hippocampus 33
5-HT7 receptor activation reverses mGluR-LTD in the hippocampus of wild-type and Fmr1 knockout mice 32
null 31
Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome 29
Serotonin 5-HT7 receptor activation rescues CA1 pyramidal neurons from mGluR-LTD in wild type and in Fmr1 knockout mice 28
The role of brain oscillations in post-stroke motor recovery: An overview 23
Modulation of synaptic transmission by PACAP in the CA1 region of hippocampus: involvement of pre- and post-synaptic mechanisms. 22
A subnanomolar concentration of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) pre-synaptically modulates glutamatergic transmission in the rat hippocampus acting through acetylcholine. 19
Potential role of novel 5-HT7 receptor agonists as pharmacological tools in Fragile X Syndrome 19
The serotonin receptor subtype 7 (5-HT7) modulates hippocampal synaptic transmission and plasticity: a possible novel therapeutic target in cognitive diseases 19
Pituitary adenylate cyclase-activating polypeptide (PACAP) Pac1 receptor activation enhances CA3-CA1 transmission in the rat hippocampus interacting with acethylcholine 18
Modulation of AMPA receptor-mediated synaptic transmission by PACAP in the rat hippocampus 17
Localization of pre-synaptic PAC1 receptors for PACAP (Pituitary Adenylate Cyclase Activating Peptide) in the CA1 region of rat hippocampus. 16
Serotonin 5-HT7 receptors require Cyclin-Dependent Kinase 5 to rescue hippocampal synaptic plasticity in a mouse model of Fragile X Syndrome 12
Increased heat pain tolerance but hyperalgesia to tonic inflammatory pain in the CRND8 mouse model of Alzheimer’s disease 5
Totale 1.800
Categoria #
all - tutte 7.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020190 0 9 1 15 5 47 21 15 2 39 26 10
2020/2021330 24 8 47 13 40 13 13 38 17 52 23 42
2021/2022215 3 38 8 14 2 2 12 13 3 0 40 80
2022/2023681 42 23 55 49 40 66 17 53 311 3 10 12
2023/2024137 14 29 15 12 10 16 9 8 1 4 3 16
2024/202519 14 5 0 0 0 0 0 0 0 0 0 0
Totale 1.800